APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,145,251 | +115.1% | 398,138 | +415.1% | 0.02% | +125.0% |
| Q2 2023 | $7,041,210 | +120.9% | 77,291 | +59.9% | 0.01% | +100.0% |
| Q1 2023 | $3,187,319 | +16.8% | 48,322 | -8.4% | 0.00% | +33.3% |
| Q4 2022 | $2,729,253 | +58.4% | 52,780 | +109.2% | 0.00% | +50.0% |
| Q3 2022 | $1,723,000 | -40.0% | 25,229 | -60.3% | 0.00% | -50.0% |
| Q2 2022 | $2,873,000 | -2.2% | 63,525 | +9.9% | 0.00% | +33.3% |
| Q1 2022 | $2,937,000 | +91.1% | 57,809 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $1,537,000 | -28.4% | 57,356 | -18.2% | 0.00% | -25.0% |
| Q4 2019 | $2,147,000 | +35.0% | 70,128 | +6.2% | 0.00% | +33.3% |
| Q3 2019 | $1,590,000 | – | 66,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |